Calculation of composite recovery time: a new pharmacodynamic parameter

Fiona MacKenzie, K. E. Milne, Ian M Gould

    Research output: Contribution to journalArticle

    1 Citation (Scopus)

    Abstract

    A new pharmacodynamic parameter, the composite recovery time (CRT), is described and used to calculate species-specific MIC breakpoints. Moxifloxacin data were used for illustration. This required determination of MICs, kill curves and post-antibiotic sub-MIC effect values. Thirteen test isolates included Staphylococcus aureus, Haemophilus influenzae and Streptococcus pneumoniae. The concentration at which the CRT equals the dosing interval is the minimum effective concentration, and is effectively the breakpoint. The breakpoints were calculated as 2 mg/L for the pneumococci and quinolone-susceptible H. influenzae isolate, 1 mg/L for staphylococci and 0.5 mg/L for Enterobacteriaceae. Calculated pharmacodynamic breakpoints were very similar to traditional published MIC breakpoints.

    Original languageEnglish
    Pages (from-to)281-284
    Number of pages3
    JournalJournal of Antimicrobial Chemotherapy
    Volume50
    Issue number2
    DOIs
    Publication statusPublished - 2002

    Keywords

    • VITRO DYNAMIC-MODEL
    • MOXIFLOXACIN
    • BREAKPOINTS
    • PREDICTION

    Cite this

    Calculation of composite recovery time: a new pharmacodynamic parameter. / MacKenzie, Fiona; Milne, K. E.; Gould, Ian M.

    In: Journal of Antimicrobial Chemotherapy, Vol. 50, No. 2, 2002, p. 281-284.

    Research output: Contribution to journalArticle

    @article{e7c5a5a1dc5842b7af720c689bee343b,
    title = "Calculation of composite recovery time: a new pharmacodynamic parameter",
    abstract = "A new pharmacodynamic parameter, the composite recovery time (CRT), is described and used to calculate species-specific MIC breakpoints. Moxifloxacin data were used for illustration. This required determination of MICs, kill curves and post-antibiotic sub-MIC effect values. Thirteen test isolates included Staphylococcus aureus, Haemophilus influenzae and Streptococcus pneumoniae. The concentration at which the CRT equals the dosing interval is the minimum effective concentration, and is effectively the breakpoint. The breakpoints were calculated as 2 mg/L for the pneumococci and quinolone-susceptible H. influenzae isolate, 1 mg/L for staphylococci and 0.5 mg/L for Enterobacteriaceae. Calculated pharmacodynamic breakpoints were very similar to traditional published MIC breakpoints.",
    keywords = "VITRO DYNAMIC-MODEL, MOXIFLOXACIN, BREAKPOINTS, PREDICTION",
    author = "Fiona MacKenzie and Milne, {K. E.} and Gould, {Ian M}",
    year = "2002",
    doi = "10.1093/jac/dkf108",
    language = "English",
    volume = "50",
    pages = "281--284",
    journal = "Journal of Antimicrobial Chemotherapy",
    issn = "0305-7453",
    publisher = "Oxford University Press",
    number = "2",

    }

    TY - JOUR

    T1 - Calculation of composite recovery time: a new pharmacodynamic parameter

    AU - MacKenzie, Fiona

    AU - Milne, K. E.

    AU - Gould, Ian M

    PY - 2002

    Y1 - 2002

    N2 - A new pharmacodynamic parameter, the composite recovery time (CRT), is described and used to calculate species-specific MIC breakpoints. Moxifloxacin data were used for illustration. This required determination of MICs, kill curves and post-antibiotic sub-MIC effect values. Thirteen test isolates included Staphylococcus aureus, Haemophilus influenzae and Streptococcus pneumoniae. The concentration at which the CRT equals the dosing interval is the minimum effective concentration, and is effectively the breakpoint. The breakpoints were calculated as 2 mg/L for the pneumococci and quinolone-susceptible H. influenzae isolate, 1 mg/L for staphylococci and 0.5 mg/L for Enterobacteriaceae. Calculated pharmacodynamic breakpoints were very similar to traditional published MIC breakpoints.

    AB - A new pharmacodynamic parameter, the composite recovery time (CRT), is described and used to calculate species-specific MIC breakpoints. Moxifloxacin data were used for illustration. This required determination of MICs, kill curves and post-antibiotic sub-MIC effect values. Thirteen test isolates included Staphylococcus aureus, Haemophilus influenzae and Streptococcus pneumoniae. The concentration at which the CRT equals the dosing interval is the minimum effective concentration, and is effectively the breakpoint. The breakpoints were calculated as 2 mg/L for the pneumococci and quinolone-susceptible H. influenzae isolate, 1 mg/L for staphylococci and 0.5 mg/L for Enterobacteriaceae. Calculated pharmacodynamic breakpoints were very similar to traditional published MIC breakpoints.

    KW - VITRO DYNAMIC-MODEL

    KW - MOXIFLOXACIN

    KW - BREAKPOINTS

    KW - PREDICTION

    U2 - 10.1093/jac/dkf108

    DO - 10.1093/jac/dkf108

    M3 - Article

    VL - 50

    SP - 281

    EP - 284

    JO - Journal of Antimicrobial Chemotherapy

    JF - Journal of Antimicrobial Chemotherapy

    SN - 0305-7453

    IS - 2

    ER -